Advisory Alpha’s Braskem BAK Stock Holding History

Advisory Alpha’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50	Closed	–	–	151
2020 Q3	$0	Buy	+50	New	+$430	﹤0.01%	696

Other funds holding BAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Advisory Alpha's BAK Position: Q4 2020 in Review

Advisory Alpha sold out of Braskem (BAK) in Q4 2020, closing a stake of 50 shares.

Advisory Alpha first reported a position in BAK in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 34 funds tracked by Wall St. Rank hold BAK as of Q4 2020.

Advisory Alpha reported no remaining Braskem position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 50 Braskem shares in Q4 2020.
Advisory Alpha first reported a position in Braskem in Q3 2020 and held it in 1 quarter.
Advisory Alpha's Braskem position peaked at $0 in Q3 2020.
34 funds tracked by Wall St. Rank held Braskem as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.